Digoxin and Simbrinza drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Digoxin (digoxin) and Simbrinza (brimonidine tartrate; brinzolamide). Common drug interactions include dizziness among females and pleural effusion among males.
The phase IV clinical study analyzes what interactions people have when they take Digoxin and Simbrinza. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.
What is Digoxin?
Digoxin has active ingredients of digoxin. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 93,740 Digoxin users. Check the latest studies of Digoxin.
What is Simbrinza?
Simbrinza has active ingredients of brimonidine tartrate; brinzolamide. It is often used in glaucoma. eHealthMe is studying from 4,543 Simbrinza users. Check the latest studies of Simbrinza.
16 people who take Digoxin and Simbrinza together, and have interactions are studied.

What are the common drug interactions of Digoxin and Simbrinza, by gender? *:
female:
- Dizziness
- Fluid retention (an abnormal accumulation of fluid in the blood)
- Insomnia (sleeplessness)
- Pneumonia
- Blood potassium decreased
- Blood pressure fluctuation
- Cardiac arrest
- Cataract (clouding of the lens inside the eye)
- Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
- Coronary artery occlusion (complete obstruction of blood flow in a coronary artery)
male:
- Pleural effusion (water on the lungs)
- Acute respiratory failure
- Cough
- Death
- Diarrhoea
- Dizziness
- Drug ineffective
- Dyspnoea exertional (breathlessness or shortness of breath)
- Fatigue (feeling of tiredness)
- Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
What are the common drug interactions of Digoxin and Simbrinza, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
n/a
50-59:
n/a
60+:
- Dizziness
- Death
- Blood pressure fluctuation
- Cardiac arrest
- Cardiac failure
- Carotid artery stenosis (narrowing of carotid artery)
- Cataract (clouding of the lens inside the eye)
- Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
- Chronic kidney disease
- Coronary artery occlusion (complete obstruction of blood flow in a coronary artery)
What are the existing conditions these people have? *
- Pulmonary Hypertension (increase in blood pressure in the lung artery): 2 people, 12.50%
- Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 2 people, 12.50%
- Iron Deficiency Anaemia: 2 people, 12.50%
- Arrhythmia Supraventricular (irregular heartbeat supraventricular origin): 2 people, 12.50%
- Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 1 person, 6.25%
- Prostate Cancer: 1 person, 6.25%
- Pain: 1 person, 6.25%
- Neurotrophic Keratopathy (decreased corneal sensitivity and poor corneal healing): 1 person, 6.25%
- Metastases To Lung (cancer spreads to lung): 1 person, 6.25%
- Dry Eyes (lack of adequate tears): 1 person, 6.25%
* Approximation only. Some reports may have incomplete information.
Do you take Digoxin and Simbrinza?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Digoxin and Simbrinza:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Digoxin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Simbrinza:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Digoxin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Simbrinza and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Guru SR, Suresh A, Padmanabhan S, Reddy A, "A Rare Case of Digoxin Associated Gingival Overgrowth", Journal of clinical and diagnostic research: JCDR, 2017 Jan .
- Lai SW, Lin CL, Liao KF, "Digoxin use may increase the relative risk of acute pancreatitis: a population-based case–control study in Taiwan", International journal of cardiology, 2015 Feb .
- Guru SR, Suresh A, Padmanabhan S, Reddy A, "A Rare Case of Digoxin Associated Gingival Overgrowth", Journal of clinical and diagnostic research: JCDR, 2017 Jan .
- Lai SW, Lin CL, Liao KF, "Digoxin use may increase the relative risk of acute pancreatitis: a population-based case–control study in Taiwan", International journal of cardiology, 2015 Feb .
How the study uses the data?
The study uses data from the FDA. It is based on digoxin and brimonidine tartrate; brinzolamide (the active ingredients of Digoxin and Simbrinza, respectively), and Digoxin and Simbrinza (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Rosuvastatin Calcium cause Paleness? - 2 seconds ago
- Could Gemcitabine cause Fibromyalgia? - 2 seconds ago
- Idiopathic Thrombocytopenic Purpura and Platelet Count Abnormal - 15 seconds ago
- Renal Disorder and Weakness - 26 seconds ago
- Immune System Disorder and Hyperkalemia - 27 seconds ago
- Could Chlorthalidone cause Depressed Mood? - 27 seconds ago
- Drug interactions of Climara and Morphine Sulfate - 49 seconds ago
- Drug interactions of Liothyronine Sodium and Vitamins - a minute ago
- Could Halcion cause Nervous System Disorder? - a minute ago
- Drug interactions of Xtandi and Flecainide Acetate - a minute ago